Effect of intravenous iron supplementation on the level of hemoglobin in revision hip and knee arthroplasty

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0005832

Enrollment

120

Registered

2021-01-27

Start date

2021-02-18

Completion date

Unknown

Last updated

2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Surgery patients are divided into two groups, one receiving ferinject before surgery and one not receiving ferinject before revision total hip and knee arthroplasty. In the receiving group, 2 a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who required revision total hip and knee arthroplasty with hemoglobin level above 10g/dl and below 16g/dl

Exclusion criteria

Exclusion criteria: Patients with hemoglobin levels below 10 g/dl or above 16 g/dl, patients with coagulation or bleeding disorders, and patients previously treated with iron medications, and allergic reactions to iron medications

Design outcomes

Primary

Measure	Time frame
hemoglobin	—

Secondary

Measure	Time frame
Blood transfusion;transfusion volume;hospital stay;hematocrit;Ferritin;transferrin	—

Countries

Korea, Republic of

Contacts

Public ContactSeung Won Choi

Chonnam National University Hospital Hwasun Hospital

Outcome results